MedPath

HALOG

HALOG SOLUTION (Halcinonide Topical Solution, USP) 0.1 % For Topical Use Only. Not For Ophthalmic Use.

Approved
Approval ID

550b8c9f-e5a8-48c4-a3ff-1a56a3caac33

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 18, 2021

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 146974886

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Halcinonide Topical

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10631-095
Application NumberNDA017823
Product Classification
M
Marketing Category
C73594
G
Generic Name
Halcinonide Topical
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 18, 2021
FDA Product Classification

INGREDIENTS (5)

HALCINONIDEActive
Quantity: 1 mg in 1 mL
Code: SI86V6QNEG
Classification: ACTIB
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HALOG - FDA Drug Approval Details